Hyperhomocysteinemia-induced myocardial injury after coronary artery bypass

Sanya Thiengburanatham1

  • 1Division of Cardiothoracic Surgery, Siriraj Hospital, Faculty of Medicine, Bangkok, Thailand. sanya_theing@yahoo.com

Insights

High homocysteine levels increase heart muscle injury after coronary artery bypass surgery, especially in patients without other risk factors. This finding highlights homocysteine as a key factor in myocardial ischemia-reperfusion injury.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Biochemistry

Background:

  • Hyperhomocysteinemia is linked to vascular oxidative stress and cardiovascular disease.
  • Atherosclerotic risk factors contribute to cardiovascular complications.
  • Myocardial ischemia-reperfusion injury is a concern after cardiac surgery.

Purpose of the Study:

  • To investigate the impact of preoperative plasma homocysteine levels on myocardial ischemia-reperfusion injury.
  • To assess the influence of other atherosclerotic risk factors in this context.
  • To determine predictors of myocardial injury following coronary artery bypass surgery.

Main Methods:

  • Prospective enrollment of 213 patients with normal renal function undergoing coronary artery bypass.
  • Measurement of preoperative plasma homocysteine and assessment of atherosclerotic risk factors.
  • Postoperative measurement of cardiac troponin T to quantify myocardial injury.

Main Results:

  • A significant association was found between hyperhomocysteinemia and elevated postoperative peak troponin T.
  • This relationship was more pronounced in patients lacking major atherosclerotic risk factors.
  • Multivariate analysis identified hyperhomocysteinemia, hypertension, and aortic crossclamp time as predictors of myocardial injury, with risk factors paradoxically modifying homocysteine's effect.

Conclusions:

  • Preoperative hyperhomocysteinemia is an independent predictor of myocardial ischemia-reperfusion injury after coronary artery bypass.
  • The presence of major atherosclerotic risk factors alters the impact of hyperhomocysteinemia on myocardial injury.
  • Managing homocysteine levels may be crucial for reducing cardiac damage in specific patient groups.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...